Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

SCR7

SCR7 is an unstable form that can be autocyclized into a stable form SCR7 pyrazine. SCR7 pyrazine is a DNA ligase IV inhibitor that blocks nonhomologous end-joining (NHEJ) in a ligase IV-dependent manner. SCR7 pyrazine increases the efficiency of Cas9-mediated homology-directed repair (HDR). SCR7 pyrazine induces cell apoptosis and has anticancer activity[1][2].

Product Specifications

CAS Number

1533426-72-0

UNSPSC

12352005

Hazard Statement

H302-H315-H319-H335

Target

Apoptosis; CRISPR/Cas9; DNA/RNA Synthesis

Type

Reference compound

Related Pathways

Apoptosis; Cell Cycle/DNA Damage

Applications

Cancer-Kinase/protease

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/SCR7.html

Purity

98.22

Solubility

DMSO : ≥ 45 mg/mL

Smiles

O=C(N1)C(/N=C/C2=CC=CC=C2)=C(NC1=S)/N=C/C3=CC=CC=C3

Molecular Formula

C18H14N4OS

Molecular Weight

334.39

Precautions

P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501

References & Citations

[1]Srivastava M, et al. An inhibitor of nonhomologous end-joining abrogates double-strand break repair and impedes cancer progression. Cell. 2012 Dec 21;151 (7) :1474-87.|[2]Lin C, et al. Increasing the Efficiency of CRISPR/Cas9-mediated Precise Genome Editing of HSV-1 Virus in Human Cells. Sci Rep. 2016 Oct 7;6:34531.|[3]Supriya V Vartak, et al. Autocyclized and Oxidized Forms of SCR7 Induce Cancer Cell Death by Inhibiting Nonhomologous DNA End Joining in a Ligase IV Dependent Manner. FEBS J. 2018 Nov;285 (21) :3959-3976.

Shipping Conditions

Room Temperature

Storage Conditions

-20°C, 3 years; 4°C, 2 years (Powder)

Scientific Category

Reference compound1

Clinical Information

No Development Reported

Citation 01

BMC Biotechnol. 2021 Jul 27;21 (1) :45.|Cell Death Discov. 2025 Aug 23;11 (1) :402.|EMBO Rep. 2019 Mar;20 (3) :e46821.|J Genet Genomics. 2021 Feb 20;48 (2) :134-146.|J Immunol. 2020 Apr 1;204 (7) :1904-1918.|J Immunother Cancer. 2022 Jan;10 (1) :e003809.|J Mol Med (Berl) . 2019 Aug;97 (8) :1183-1193.|Mol Ther Nucleic Acids. 2024 Jul 17;35 (3) :102274.|Onco Targets Ther. 2018 Aug 17:11:4945-4953.|Sens Actuators B Chem. 19 February 2022, 131598.|Stem Cell Res Ther. 2024 Dec 2;15 (1) :458.|Viruses. 2023 Nov 14;15 (11) :2256.|Int J Mol Sci. 2022 Jul 7;23 (14) :7518.|Int J Mol Sci. 2025 May 3;26 (9) :4361.|Nat Commun. 2025 Jul 15;16 (1) :6502.|Sci Adv. 2025 Jul 11;11 (28) :eadw1720.|Trends Biotechnol. 2025 Aug 30:S0167-7799 (25) 00314-2.|Trends Biotechnol. 2025 Jul;43 (7) :1743-1764.|University of Georgia. 2025.|Virology. 2025 May:606:110504.

Available Sizes

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

MetE Antibody
orb820840 2 mg

MetE Antibody

Sign In for Pricing
View Details
Junctional Adhesion Molecule 1 (JAM 1, JAM-1, JAM1, CD321, F11 Receptor, F11R, Junctional Adhesion Molecule A, JAMA, JCAM, KAT, Platelet Adhesion Molecule 1, PAM1, Platelet F11 Receptor, UNQ264/PRO301) (APC)
J8009-04E1-APC 100 µL

Junctional Adhesion Molecule 1 (JAM 1, JAM-1, JAM1, CD321, F11 Receptor, F11R, Junctional Adhesion Molecule A, JAMA, JCAM, KAT, Platelet Adhesion Molecule 1, PAM1, Platelet F11 Receptor, UNQ264/PRO301) (APC)

Sign In for Pricing
View Details
CR1 Antibody
orb3053661-01 50 µL

CR1 Antibody

Sign In for Pricing
View Details
CR1 Antibody
orb3053661-02 100 µL

CR1 Antibody

Sign In for Pricing
View Details
Mouse Anti-tartrate acid phosphatase 5b (TRACP-5b) ELISA Kit
orb2810336-01 48 Tests

Mouse Anti-tartrate acid phosphatase 5b (TRACP-5b) ELISA Kit

Sign In for Pricing
View Details
Mouse Anti-tartrate acid phosphatase 5b (TRACP-5b) ELISA Kit
orb2810336-02 96 Tests

Mouse Anti-tartrate acid phosphatase 5b (TRACP-5b) ELISA Kit

Sign In for Pricing
View Details